Agustín Carlos Martín-García, María García de Pedro, Ana Martín-García, Leyre Álvarez-Rodríguez, Beatriz Plata-Izquierdo, Pedro Luis Sánchez-Fernández
{"title":"Salud mental en adultos con cardiopatías congénitas: el componente olvidado en el seguimiento especializado","authors":"Agustín Carlos Martín-García, María García de Pedro, Ana Martín-García, Leyre Álvarez-Rodríguez, Beatriz Plata-Izquierdo, Pedro Luis Sánchez-Fernández","doi":"10.1016/j.recesp.2026.04.002","DOIUrl":"10.1016/j.recesp.2026.04.002","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 11","pages":"Pages 981-983"},"PeriodicalIF":4.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149346271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
David García-Escrivá, José Pérez-Silvestre, Julio Núñez, Jesús Casado, José Luís Morales-Rull, Marta Sánchez-Marteles, Alicia Conde-Martel, Pau Llàcer, Prado Salamanca-Bautista, Miguel Ángel Plasín, José Manuel Cerqueiro, Paloma Gil, Luís Manzano, Francesc Formiga, Joan Carles Trullàs, en nombre de los investigadores del ensayo CLOROTIC
{"title":"Cloruro sérico y respuesta a hidroclorotiacida en pacientes con insuficiencia cardiaca aguda: un análisis post hoc del ensayo CLOROTIC","authors":"David García-Escrivá, José Pérez-Silvestre, Julio Núñez, Jesús Casado, José Luís Morales-Rull, Marta Sánchez-Marteles, Alicia Conde-Martel, Pau Llàcer, Prado Salamanca-Bautista, Miguel Ángel Plasín, José Manuel Cerqueiro, Paloma Gil, Luís Manzano, Francesc Formiga, Joan Carles Trullàs, en nombre de los investigadores del ensayo CLOROTIC","doi":"10.1016/j.recesp.2026.04.010","DOIUrl":"10.1016/j.recesp.2026.04.010","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Hypochloremia is associated with worse prognosis and diuretic resistance in acute heart failure (AHF). This study investigated whether serum chloride is associated with the efficacy and safety of hydrochlorothiazide in patients with AHF.</div></div><div><h3>Methods</h3><div>This post-hoc analysis included all 230 patients from the CLOROTIC (Safety and efficacy of the combination of loop with thiazide-type diuretics in patients with decompensated heart failure) trial, randomized to oral hydrochlorothiazide or placebo in addition to intravenous furosemide. The impact of baseline serum chloride on the treatment effect of hydrochlorothiazide on the main trial endpoints was assessed.</div></div><div><h3>Results</h3><div>At baseline, hypochloremia (< 96 mmol/L) and hyperchloremia (> 106 mmol/L) were observed in 17% and 9% of patients, respectively. The effect of hydrochlorothiazide was more pronounced in patients with hypo- or normochloremia than in those with hyperchloremia for several efficacy endpoints (weight loss at 72 or 96<!--> <!-->hours, 24-hour diuresis, and diuresis per milligram of furosemide); only weight loss at 72<!--> <!-->hours showed a significant interaction (<em>P</em> <!--> <!-->=<!--> <!--> .02). However, when baseline chloride was modeled as a continuous variable, no significant interaction was observed with primary or secondary efficacy endpoints. Similarly, no significant interaction was found between serum chloride and the effect of hydrochlorothiazide on mortality or rehospitalization. Regarding safety endpoints, baseline hypochloremia was significantly associated with an increased risk of hypokalemia (potassium<!--> <!--><<!--> <!--> 3.5 mmol/L) in patients allocated to hydrochlorothiazide (<em>P</em> <!--> <!-->=<!--> <!--> .029), with no significant interaction between hydrochlorothiazide and baseline chloride for the other safety outcomes.</div></div><div><h3>Conclusions</h3><div>In patients with AHF, the addition of hydrochlorothiazide to loop diuretics enhances decongestion regardless of the baseline serum chloride. (ClinicalTrials.gov: NCT01647932; EudraCT Number: 2013-001852-36).</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 11","pages":"Pages 911-922"},"PeriodicalIF":4.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149353319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Francisco González-Vílchez, Raquel López-Vilella, Manuel Gómez-Bueno, María G. Crespo-Leiro, Manuel Cobo-Belaustegui, Manuel Crespín-Crespín, Carlos Ortiz-Bautista, Andrea Severo-Sánchez, Laura Triguero-Llonch, Elena García-Romero, en representación de los colaboradores de los equipos españoles de trasplante cardiaco
{"title":"Registro español de trasplante cardiaco. XXXVII informe oficial de la Asociación de Insuficiencia Cardiaca de la Sociedad Española de Cardiología","authors":"Francisco González-Vílchez, Raquel López-Vilella, Manuel Gómez-Bueno, María G. Crespo-Leiro, Manuel Cobo-Belaustegui, Manuel Crespín-Crespín, Carlos Ortiz-Bautista, Andrea Severo-Sánchez, Laura Triguero-Llonch, Elena García-Romero, en representación de los colaboradores de los equipos españoles de trasplante cardiaco","doi":"10.1016/j.recesp.2026.06.018","DOIUrl":"10.1016/j.recesp.2026.06.018","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>The Spanish Heart Transplant Registry is updated annually with data on all heart transplants (HTs) performed in Spain. This report includes data through 2025. In particular, it analyzes the main characteristics of HTs performed over the past decade (2016-2025).</div></div><div><h3>Methods</h3><div>We performed a descriptive analysis of recipient and donor characteristics, surgical procedures, and follow-up events, as well as their temporal trends since 2016. Data were collected prospectively using a standardized electronic data collection form.</div></div><div><h3>Results</h3><div>In 2025, 390 HTs were performed, the highest annual number recorded in the registry, with 7% performed in pediatric recipients. Since 2016, significant trends have been observed toward lower rates of respiratory disease, previous cardiac surgery, mechanical ventilation, and serum bilirubin levels before HT, together with increased use of extracorporeal membrane oxygenation as pretransplant support. Donors were younger, and ischemic times were shorter. The use of controlled donation after circulatory death increased markedly, accounting for 35% of all HTs performed in 2025. Survival improved (85.5% at 1 year among patients transplanted in 2022-2024), and early mortality (within 30 days) declined to 7.5% in 2025 despite a significant increase in the incidence of severe primary graft dysfunction.</div></div><div><h3>Conclusions</h3><div>HT activity has increased over the past 5 years, largely driven by the growing use of controlled donation after circulatory death. The improvements in early and mid-term survival are confirmed.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 11","pages":"Pages 943-952"},"PeriodicalIF":4.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149353400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Zixiang Ye, Jiaxi Cheng, Joost Daemen, Roberto Diletti, Luca Testa, José M. de la Torre-Hernández, Shengnan Liu, Haoyu Wang, Enmin Xie, Adrian P. Banning, Kefei Dou, Ernest Spitzer
{"title":"Puntuación SYNTAX para la evaluación de la carga y complejidad de la enfermedad arterial coronaria: pasado, presente y futuro","authors":"Zixiang Ye, Jiaxi Cheng, Joost Daemen, Roberto Diletti, Luca Testa, José M. de la Torre-Hernández, Shengnan Liu, Haoyu Wang, Enmin Xie, Adrian P. Banning, Kefei Dou, Ernest Spitzer","doi":"10.1016/j.recesp.2026.06.011","DOIUrl":"10.1016/j.recesp.2026.06.011","url":null,"abstract":"<div><div>The anatomical synergy between percutaneous coronary intervention with TAXUS and cardiac surgery (SYNTAX) score remains a cornerstone for quantifying coronary artery disease complexity and guiding decisions between percutaneous coronary intervention and coronary artery bypass grafting. Developed from the SYNTAX trial in 2009, the score uses a standard methodological approach to systematically define coronary lesion attributes and yields an overall score that allows stratification of coronary complexity. A commonly accepted stratification divides patients into low (≤ 22), intermediate (23-32), and high (≥ 33) SYNTAX score, with higher categories associated with an increased risk of adverse cardiovascular events. This review article traces the history, evolution, and integration of the SYNTAX score in ESC and ACC/AHA guidelines. We also discuss its role in clinical trials and its contribution to Heart Team deliberations in patients with complex coronary artery disease. Patient benefits include adding precision for treatment selection with a historical potential to lower mortality in high-score cases by favoring coronary artery bypass grafting. Artificial intelligence and advanced imaging, such as coronary computed tomography angiography, are advancing automated, noninvasive SYNTAX score computation with superior accuracy. Future directions involve artificial intelligence-hybrid models for real-time, personalized assessments. This review article evaluates the enduring impact of the SYNTAX score and its evolving role in precision medicine.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 11","pages":"Pages 964-977"},"PeriodicalIF":4.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149353313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alessia Callegari, Mattia Bernardinetti, Margaux Bernardini, Nicolas Garcelon, Neil Derridj, Damien Bonnet, Regis Gaudin, Olivier Raisky, Sophie Malekzadeh-Milani
{"title":"Factores de riesgo de reintervención precoz en pacientes con homoinjertos criopreservados en posición pulmonar","authors":"Alessia Callegari, Mattia Bernardinetti, Margaux Bernardini, Nicolas Garcelon, Neil Derridj, Damien Bonnet, Regis Gaudin, Olivier Raisky, Sophie Malekzadeh-Milani","doi":"10.1016/j.recesp.2026.05.008","DOIUrl":"10.1016/j.recesp.2026.05.008","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Cryopreserved homograft implantation in the pulmonary position is a common surgical approach for pulmonary valve replacement, although it carries a risk of early failure requiring reintervention. This study aimed to identify clinical, anatomical, surgical, graft, and postoperative factors associated with early failure, defined as reintervention (percutaneous or surgical) within 3 years.</div></div><div><h3>Methods</h3><div>In this retrospective cohort study (2017-2024), we included 136 patients (median weight 45.0 [IQR: 25.25-60.00] kg; age 14.11 [8.31-18.09] years) who received a homograft in the pulmonary position. Time-to-event analyses were performed to identify factors associated with early failure, including multivariable Cox proportional hazards regression.</div></div><div><h3>Results</h3><div>The most frequent underlying conditions were tetralogy of Fallot in 44.0% and common arterial trunk in 16.9%. The median homograft size was 22 [19-24] mm, and 15 (11%) were aortic homografts. The median follow-up was 4.15 [1.61-5.00] years. Eighteen patients (13.2%) required reintervention at a median of 1.29 [0.72-1.93] years. Reasons for reintervention included postimplantation due to stenosis (n<!--> <!-->=<!--> <!-->8), stenosis and infective endocarditis (n<!--> <!-->=<!--> <!-->1), and stenosis and regurgitation (n<!--> <!-->=<!--> <!-->9). Interventions included percutaneous pulmonary valve implantation (n<!--> <!-->=<!--> <!-->5), homograft dilatation (n<!--> <!-->=<!--> <!-->3), stenting (n<!--> <!-->=<!--> <!-->3), and surgical replacement or heterograft implantation (n<!--> <!-->=<!--> <!-->7). Univariate analysis identified significant associations with fever, fever without documented infection, pericardial/mediastinal collection necessitating reintervention, and elevated RVOT velocity on echo (> 2.1 m/s) at discharge. On multivariable Cox regression analysis, fever without documented infection remained independently associated with earlier reintervention (HR, 4.42; 95%<span>C</span>I, 1.34-14.52; <em>P</em> <!-->=<!--> <!-->.014).</div></div><div><h3>Conclusions</h3><div>Early reintervention is associated with postoperative inflammatory markers and immediate suboptimal homograft function. These findings support and refine previous observations on early homograft dysfunction and may help identify patients who warrant closer postoperative surveillance.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 11","pages":"Pages 902-910"},"PeriodicalIF":4.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149353318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rafael de la Espriella, Enrique Santas, Gema Miñana, Miguel Lorenzo, Gonzalo Núñez, Anna Mollar, Enrique Rodríguez, Antoni Bayés-Genís, Marat Fudim, Mark C. Petrie, Kieran F. Docherty, Vicent Bodí, Juan Sanchis, Eduardo Núñez, Julio Núñez
{"title":"Valor pronóstico de las trayectorias del antígeno carbohidrato 125 durante la fase de transición tras el ingreso por insuficiencia cardiaca aguda","authors":"Rafael de la Espriella, Enrique Santas, Gema Miñana, Miguel Lorenzo, Gonzalo Núñez, Anna Mollar, Enrique Rodríguez, Antoni Bayés-Genís, Marat Fudim, Mark C. Petrie, Kieran F. Docherty, Vicent Bodí, Juan Sanchis, Eduardo Núñez, Julio Núñez","doi":"10.1016/j.recesp.2026.05.004","DOIUrl":"10.1016/j.recesp.2026.05.004","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>The early postdischarge period after acute heart failure (AHF) hospitalization is marked by high rates of rehospitalization and death, largely driven by residual congestion. Carbohydrate antigen 125 (CA125) is a congestion-sensitive biomarker, yet the prognostic value of its longitudinal trajectory after AHF remains poorly characterized. We aimed to determine whether serial CA125 measurements during the first 6 months postdischarge predict heart failure (HF) rehospitalization and all-cause mortality.</div></div><div><h3>Methods</h3><div>This single-center cohort study included 3980 consecutive AHF patients (October 2008-February 2023) with 6975 serial CA125 measurements (median follow-up, 161.5 days). Log-transformed CA125 trajectories were modeled using spline-fitted joint models linking longitudinal biomarker evolution with recurrent HF rehospitalizations (joint frailty model) and all-cause mortality (Weibull hazard), with adjustment for established clinical covariates.</div></div><div><h3>Results</h3><div>During follow-up, 814 rehospitalizations occurred in 549 patients (20.5%) and there were 604 deaths (15.2%). CA125 displayed a biphasic trajectory: an early postdischarge peak around day 10, a steep decline within the first month, and a gradual reduction thereafter (<em>P</em> <<!--> <!-->.001). In joint modeling, each log-unit increase in CA125 was associated with a 27% higher risk of recurrent HF rehospitalization (HR, 1.27; 95%CI, 1.17-1.37; <em>P</em> <<!--> <!-->.001), an association that remained constant over time. The association with mortality was time-dependent (<em>P</em> for interaction <<!--> <!-->.001), strongest within the first 60 days (HR, ∼1.70), and nonsignificant thereafter.</div></div><div><h3>Conclusions</h3><div>In patients with AHF, serial CA125 measurements display a distinct postdischarge trajectory and independently predict recurrent HF rehospitalizations and early mortality. These findings support the integration of CA125 monitoring into postdischarge management to guide risk stratification and decongestive therapy.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 11","pages":"Pages 923-933"},"PeriodicalIF":4.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149353398","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sara Ruiz-Magaña, José Antonio Fernández-Sánchez, Víctor Manuel López-Espinosa
{"title":"Miocardiopatía hipertrófica en el contexto de diabetes e hipoacusia congénita","authors":"Sara Ruiz-Magaña, José Antonio Fernández-Sánchez, Víctor Manuel López-Espinosa","doi":"10.1016/j.recesp.2026.03.011","DOIUrl":"10.1016/j.recesp.2026.03.011","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 11","pages":"Pages 991-993"},"PeriodicalIF":4.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149353993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ángela Hernández, João Paulo Madeiro, Roberto C. Pedrosa, Pablo Laguna, Julia Ramírez
{"title":"Valor clínico de marcadores derivados del ECG para la estratificación de riesgo de parada súbita cardiaca en la miocardiopatía chagásica","authors":"Ángela Hernández, João Paulo Madeiro, Roberto C. Pedrosa, Pablo Laguna, Julia Ramírez","doi":"10.1016/j.recesp.2026.05.003","DOIUrl":"10.1016/j.recesp.2026.05.003","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Sudden cardiac arrest (SCA) is a significant complication in the spectrum of Chagas cardiomyopathy (CC) among infected individuals. Although the Rassi score (RS) is the most established tool for predicting mortality, a nonnegligible proportion of low- or intermediate-risk CC patients still experience SCA. This study aimed to evaluate whether electrocardiogram (ECG)-derived ventricular repolarization indices, when combined with the RS, improve SCA risk stratification in low- or intermediate-risk CC patients.</div></div><div><h3>Methods</h3><div>We analyzed 24-hour ECGs from 144 chronic CC patients to derive QT (Δα<sup>QT</sup>), T-peak-to-end (Δα<sup>Tpe</sup>), T-wave morphology (TMR), and T-peak-to-end morphology (TpeMR) restitution indices. Cox regression models, adjusted for RS, assessed the independent predictive value of each index for SCA. A combined risk model was developed by combining the strongest predictors with RS.</div></div><div><h3>Results</h3><div>Δα<sup>Tpe</sup> showed the strongest association with SCA (<em>P</em> <<!--> <!-->.001) and remained an independent predictor alongside RS and hypertension (HR, 13.6; <em>P</em> <!-->=<!--> <!-->.020). The combined risk model improved sensitivity, balanced accuracy, and negative predictive value for identifying high-risk patients compared with RS alone, although it showed a reduction in specificity and positive predictive value. Moreover, the combined risk model maintained overall discrimination (HR, 23.1 vs RS alone HR, 17.8; both <em>P</em> <<!--> <!-->.001), providing complementary prognostic information.</div></div><div><h3>Conclusions</h3><div>Δα<sup>Tpe</sup> was independently associated with SCA risk in CC. Its combination with the RS improved the identification of high-risk patients but was less effective at detecting low-risk individuals, suggesting a complementary rather than superior role to the RS.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 11","pages":"Pages 934-942"},"PeriodicalIF":4.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149353399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Julia Playán-Escribano, Carlos Labrandero de Lera, Leticia Albert de la Torre, Alejandro Rodríguez-Ogando, Antonio Moreno-Galdó, Inmaculada Guillén Rodríguez, Anna Sabaté-Rotés, Amparo Moya-Bonora, Lina María Caicedo Cuenca, María Jesús Cerro-Marín, en representación de los investigadores del registro REHIPED
{"title":"Adaptación de la escala REVEAL Lite 2 a la población pediátrica mediante el aprendizaje automático: aportación del registro REHIPED","authors":"Julia Playán-Escribano, Carlos Labrandero de Lera, Leticia Albert de la Torre, Alejandro Rodríguez-Ogando, Antonio Moreno-Galdó, Inmaculada Guillén Rodríguez, Anna Sabaté-Rotés, Amparo Moya-Bonora, Lina María Caicedo Cuenca, María Jesús Cerro-Marín, en representación de los investigadores del registro REHIPED","doi":"10.1016/j.recesp.2026.03.010","DOIUrl":"10.1016/j.recesp.2026.03.010","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Risk scores for pulmonary hypertension (PH) have been proven useful in adults. However, no risk score has been validated in pediatric populations. Our aim was to adapt the REVEAL Lite 2 score to pediatrics, including groups 1 (pulmonary arterial hypertension) and 3 (PH associated with lung diseases).</div></div><div><h3>Methods</h3><div>Data from the REHIPED was used, which is the PH registry of the Spanish Society of Pediatric Cardiology and Congenital Heart Disease. The registry also incorporates some Colombian centers. Patients in group 1 and group 3 were included. The score was derived using machine learning. The contribution of each variable and its cutoffs were identified through gradient boosting. The REVEAL Lite 2 variables were normalized and entered into the model, along with each patient's weight, sex, and age. Risk stratification into 3 categories (low, intermediate, and high risk) was performed.</div></div><div><h3>Results</h3><div>A total of 420 children were analyzed. The final model included functional class, age at diagnosis, heart rate, weight-for-height percentile, systolic blood pressure, natriuretic peptides, weight-for-age percentile, and 6-minute walk test. The area under the curve was 0.82, with an estimated area under the curve of 0.73 on unseen data. The log-rank <em>P</em> value for differences in transplant-free survival among the 3 risk strata (low, intermediate, and high) was<!--> <!--><<!--> <!-->.001. HR for intermediate risk vs low risk was 3.10 (95%CI, 1.02-9.40; <em>P</em> <!-->=<!--> <!-->.046), and HR for high risk vs low risk was 12.30 (95%CI, 4.42-34.25; <em>P</em> <<!--> <!-->.001).</div></div><div><h3>Conclusions</h3><div>Our score adequately stratifies the risk of PH in the pediatric population, including infants, and is based on noninvasive variables.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"79 11","pages":"Pages 886-898"},"PeriodicalIF":4.2,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149353316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}